Library and post-translational modifications of peptide-based display systems.

Hanna Dotter1, Melanie Boll1, Matthias Eder1

  • 1Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany; Division of Radiopharmaceutical Development, German Cancer Consortium, partner site Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany, and German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Biotechnology Advances
|January 29, 2021
PubMed
Summary

Biotechnological display methods accelerate drug discovery. Chemical modifications enhance peptide drug candidate stability and affinity, overcoming key limitations in targeted therapies.